Karen Lynch, MD, MRCPI, senior global medical director at Sanofi, discusses how delayed diagnosis in CIDP can contribute to irreversible nerve damage, long-term disability, and reduced functional recovery. [WATCH TIME: 3 minutes]
Karen Lynch, MD, MRCPI
Advertisement
Articles by Karen Lynch, MD, MRCPI
The senior global medical director at Sanofi discussed the ongoing burden of CIDP, highlighting diagnostic challenges, treatment gaps, and the need for improved biomarkers and emerging therapies. [WATCH TIME: 3 minutes]
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Discontinuing Disease-Modifying Therapy in Older Patients With MS: John Corboy, MD
2
SKY-0515 Reduces mHTT, Alexion C5 inhibitors Reduces Relapse Rate, Exploring Stem Cell Innovation in PD
3
Stem Cell Therapy Versus Traditional Parkinson Treatments
4
A Call for Greater Education in Stem Cell Therapies
5